MATTHEW D PERRY Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for MATTHEW D PERRY.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of MATTHEW D PERRY. MATTHEW D PERRY is a Director in CTI BIOPHARMA CORP ($CTIC) and a Director in XOMA Corp ($XOMA).

Address: ONE SANSOME STREET 31ST FLOOR SAN FRANCISCO 94104 CA

Companies in which MATTHEW D PERRY is an Insider

CTI BIOPHARMA CORP

Trading Symbol: CTIC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MATTHEW D PERRY: Director
Holdings: 43,139 shares
Current Value: $201,459
Latest Transaction: Mar 12 2021
$CTIC Market Capitalization: $129.36M
$CTIC Previous Close: $4.67

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

XOMA Corp

Trading Symbol: XOMA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MATTHEW D PERRY: Director
Holdings: 200,000 shares
Current Value: $842,000
Latest Transaction: Dec 15 2020
$XOMA Market Capitalization: $25.10M
$XOMA Previous Close: $4.21

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of MATTHEW D PERRY

Sentiment: All, CTIC, XOMA

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 12 2021CTICCTI BIOPHARMA CORPPERRY MATTHEW DDirectorOption ExerciseA3.3080,000264,00080,000
Dec 15 2020XOMAXOMA CorpPERRY MATTHEW DDirectorBuyP25.00200,0005,000,000200,0000 to 200 K
May 27 2020XOMAXOMA CorpPERRY MATTHEW DDirectorOption ExerciseA21.276,152130,8536,152
May 27 2020XOMAXOMA CorpPERRY MATTHEW DDirectorOption ExerciseA21.276,152130,8536,152
May 20 2019CTICCTI BIOPHARMA CORPPERRY MATTHEW DDirectorOption ExerciseA0.84120,000100,932120,000
May 20 2019XOMAXOMA CorpPERRY MATTHEW DDirectorOption ExerciseA15.598,167127,3248,167
May 21 2018CTICCTI BIOPHARMA CORPPERRY MATTHEW DDirectorOption ExerciseA4.6160,000276,60060,000

View all MATTHEW D PERRY insider transactions.